Search

Your search keyword '"Jutel, M."' showing total 58 results

Search Constraints

Start Over You searched for: Author "Jutel, M." Remove constraint Author: "Jutel, M." Database Unpaywall Remove constraint Database: Unpaywall
58 results on '"Jutel, M."'

Search Results

1. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study

2. From MASK-air® and SILAM to CATALYSE (Climate Action to Advance HeaLthY Societies in Europe)

3. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

4. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

5. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

9. Allergen-Immuntherapie in der aktuellen COVID-19-Pandemie – ein Positionspapier von ARIA, EAACI, AeDA, GPA und DGAKI (Kurzversion) – Positionspapier der deutschen ARIA-GruppeA in Kooperation mit der österreichischen ARIA-GruppeB, der schweizerischen ARIA-GruppeC, dem Ärzteverband Deutscher Allergologen (AeDA)D, der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)E und der Gesellschaft für Pädiatrische Allergologie (GPA)F in Kooperation mit der AG Klinische Immunologie, Allergologie und Umweltmedizin der DGHNO-KHCG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H

10. Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation – summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019

11. ARIA-Leitlinie 2019: Behandlung der allergischen Rhinitis im deutschen Gesundheitssystem

12. Prioritizing Research Challenges and Funding for Allergy and Asthma and the Need for Translational Research — The European Strategic Forum on Allergic Diseases

14. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

15. ARIA guideline 2019: treatment of allergic rhinitis in the German health system

17. The urgent need for a harmonized severity scoring system for acute allergic reactions

18. EAACI guidelines on allergen immunotherapy: Executive statement

19. Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project

20. Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy

21. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy

22. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

23. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

24. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis

25. Altered fatty acid metabolism and reduced stearoyl‐coenzyme a desaturase activity in asthma

26. Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper

27. European symposium on the awareness of allergy: report of the promotional campaign in the European Parliament (26-28 April 2016)

28. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

29. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

30. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

31. EAACI Molecular Allergology User's Guide

32. In vivodiagnosis of allergic diseases-allergen provocation tests

34. First European data from the network of severe allergic reactions (NORA)

35. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine

36. Recommendations for the allergy management in the primary care

41. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union

45. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease

Catalog

Books, media, physical & digital resources